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BACKGROUND: The effect of the menopause and HRT on the intervertebral discs has not been investigated.
METHODS: One hundred women were recruited, comprising of 44 post-menopausal women on HRT, 33 untreated
post-menopausal women and 23 pre-menopausal women. The height of the intervertebral discs between the 12th tho-
racic vertebra and the 3rd lumbar vertebra was measured by utilizing the bone densitometer height cursors.
RESULTS: The untreated menopausal group of women had the lowest total disc height (D1–D3: 1.95 ± 0.31 cm). This
was significantly lower than the pre-menopausal group D1–D3: 2.16 ± 0.24 cm) and the hormone-treated group (2.2 ±
0.26 cm) (P > 0.02). The 2nd intervertebral disc consistently maintained a significant difference between the
untreated menopausal group (D2: 0.63 ± 0.13) and the other two groups (pre-menopausal group (D2: 0.72 ± 0.09 cm)
and treated menopausal group (D2: 0.73 ± 0.12 cm) (P > 0.02). CONCLUSIONS: Estrogen-replete women appear to
maintain higher intervertebral discs compared to untreated post-menopausal women. The estrogenic milieu may be
relevant because of the significant impact it has on the hydrophilic glycosaminoglycans, the water content, collagen
and elastin of the intervertebral discs. The maintenance of adequate disc height may allow the intervertebral discs to
retain their discoid shape and viscoelastic function, containing vertical forces which may threaten spinal architecture
leading to vertebral body compression fractures.
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Introduction
Loss of spinal height in post-menopausal women is mainly
attributed to osteoporotic vertebral fractures. In the late 1930s,
loss of spinal height due to vertebral fractures was noted in
women who had undergone a surgical menopause. Albright
et al. (1940) demonstrated the increased risk of osteoporotic
fractures in oophorectomized women or women who had
undergone a premature menopause.
Another important component of the spinal column which
may influence spinal height is the intervertebral discs. Interver-
tebral discs are responsible for 25% of the spinal column
height (Williams and Warwick, 1980). To date not much
work has been done on intervertebral discs in relation to post-
menopausal vertebral fractures (Goh et al., 1999; Muscat Baron,
2002; Urban and Roberts, 2003). Besides allowing flexion,
extension and torsion of the spine, the intervertebral discs have
important biomechanical properties. One important function is
that the intervertebral discs act as shock absorbers, which may
be relevant in the pathogenesis of vertebral fracture. Moreover
besides the shock absorbing characteristics, the intervertebral
discs interact with the central nervous system and the spinal
musculature through the presence of mechanoreceptors, which
relay information regarding the pressures applied to the discs.
This property allows greater distribution of the forces applied
to the spinal column (Roberts et al., 1995).
Recent studies utilizing vertebral fractures as the endpoints
have further emphasized the importance of the extracellular
matrix in the pathogenesis and prevention of vertebral frac-
tures. In the MORE (Multiple Outcomes of Raloxifene Evalua-
tion) study with an increase of only 4% bone mineral density, a
50% reduction in vertebral fractures was noted (Ettinger et al.,
1999). The increase in bone mineral density was calculated to
be responsible for only 14% of the reduction in vertebral frac-
tures. Similar patterns were noted in the FITS (Fracture Inter-
vention Study) and the VERT (Vertebral Efficacy with
Residronate) studies whereby the fracture reduction attributa-
ble to the increase in bone mineral density was only 28 and
14% respectively (Cummings et al., 1998; Harris et al., 1999).
In all three studies the trend of collagen markers veered towards
bone formation rather the bone breakdown. All the above work
suggests that besides the bone mineral density, the extracellular
matrix of all the components of the spinal column may have a
large part to play in the osteoporotic process of the spine.
This study involved the measurement of the intervertebral
disc height in three different groups of women: menopausal
women on hormone treatment, untreated post-menopausal
women and pre-menopausal. The aim of the study was to
assess whether intervertebral disc height varied between these
three different groups of women possibly due to the influence
of their estrogenic status.
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Materials and methods
One hundred women were recruited from a bone density directory.
Every fifth woman was selected to reduce bias. The woman’s
information sheet was assessed to segregate the woman according to
her menstrual status and if menopausal, to note what treatment she
was receiving. Exclusion criteria were women with endocrinopathies,
treatment with bisphosphonates, and long term treatment with corti-
costeroids. Conditions which may affect bone density such as renal
disease, thyroid disease and malignancy were also employed as exclu-
sion criteria. A history of tobacco smoking and/or alcohol ingestion of
more than two units a day were also considered exclusion criteria.
There were no obvious differences in life style between the three dif-
ferent groups of women. If the woman selected was excluded the fol-
lowing woman (sixth) was recruited instead.
The bone density assessments were performed on these women as a
form of screening for osteoporosis. The demographic data and bone
density results were comparable to those obtained in a larger popula-
tion utilised in another study indicating that the women recruited in
this study were a representative population (Muscat Baron et al.,
1999).
Intervertebral disc measurement involved retrieving the image of
the selected woman’s vertebral bone scan. On obtaining the image, the
computer software was adapted so as to apply the screen cursors on to
the edges of the vertebrae. Usually these cursors are used to measure
the vertebral body height. Five readings were taken of each disc and
an average of these readings was taken.
The intervertebral discs measured were those between the 12th tho-
racic and 4th lumbar vertebra. The discs were assigned the symbol D,
so that D1 applied to the disc between the 12th thoracic vertebra and
the first lumbar vertebra and the other discs followed suit, i.e. D2, D3,
D4. The last intervertebral disc could not be measured consistently
and therefore was excluded from analysis. When difficulty arose on
measuring the intervertebral disc height due a variety of reasons as in
the presence of osteoarthrosis, the grey scale adjacent to the vertebral
image was used to increase the accuracy of the disc height measure-
ment.
All measurements were performed by the same operator who was
blinded to the menstrual or treatment status of the woman. The error
of the method was calculated to be 0.03mm. The coefficient of varia-
tion was calculated from the variation from the mean of the total disc
height (D1–D3) from the same bone density image. Twenty measure-
ments from the same three discs, on four different occasions were
taken giving a coefficient of variation of 2.8%. Ethics approval was
obtained from the Malta Medical School Ethics Committee.
Statistical methods
The variables in this study including the demographic characteristics,
the intervertebral disc height and T-score were applied to Normality
plots to assess their distribution. For distributions of these variables
the Normality plots allowed the utilization of the Mann–Whitney U-test.
P < 0.05 was considered significant. Power calculations indicated that
a minimum number of 20 patients was required in each group of
women to identify a 10% difference in disc height allowing for an
alpha value of 5% and power of 80%.
Results
Out of a total of 100 women recruited, 44 women were on hor-
mone replacement therapy for 3 ± 1.5 years, 23 were pre-
menopausal women while 33 were untreated menopausal women.
Of the women treated with hormone therapy, 15 were on con-
jugated estrogens (conjugated estrogens 0.625 mg and 1 mg
norgestrel), 19 were on different formulations of oral 2 mg
estradiol and progestin, six women were on transdermal estro-
gen and three women were on estradiol implants. The women
on estradiol implants and six women on transdermal estrogen
had had hysterectomies and bilateral salpingo-oophorectomies
and therefore were not given progestins. Both in the hormone
treated group and the untreated group there were women who
had hysterectomies and salpingo-oophorectomies at an early
age, and this may explain the low age of menopause in these
groups of women.
The pre-menopausal group was significantly younger than
the treated and untreated groups. These pre-menopausal
women whose mean age was 49.7 ± 4.0 years, close to the age
of the menopause transition, were referred for a bone density
assessment in most cases for back pain. There was no signific-
ant difference in the age and menopausal age of the treated and
untreated menopausal women. The demographic characteris-
tics of the women are shown in Table I.
Significant differences were noted when comparing the
intervertebral disc height of the three groups of women. The
untreated menopausal group of women had the lowest total
disc height (total disc height D1–D3: 1.96 ± 0.31 cm) (Table I).
This was significantly lower than that of the pre-menopausal
group (2.16 ± 0.23 cm) (Table I) and the hormone-treated
group (2.2 ± 0.26 cm) (P > 0.02) (Figure 1). The second
intervertebral disc (D2) consistently maintained a significant
difference between the untreated menopausal group (0.62 ±
0.12) and the other two groups (pre-menopausal group 0.72 ±
0.09 cm and treated menopausal group 0.73 ± 0.12 cm) (P >
0.02) (Figure 2). The T-score and women’s total height were
lowest in the untreated menopausal group, but these differ-
ences did not reach statistical significance.
Discussion
The results of this study indicate that the women with adequate
estrogen levels had significantly greater disc heights compared
Table I. Demographic characteristics of women recruited in the study
*P < 0.05, **P < 0.02.
D = disc; N/A = not applicable.
n Height (cm) Weight (kg) Age (years) Age at 
menopause
(years)
D1 (cm) D2 (cm) D3 (cm) D1–D3 (cm) T-Score
Untreated group 33 154.7 ± 6.8 68.6 ± 13.5 54.7 ± 8.1 46.1 ± 5.9 0.68 ± 0.14 0.62 ± 0.12 0.65 ± 0.15 1.96 ± 0.31 –0.8 ± 0.69
Pre-menopausal group 23  156 ± 5.6 66.9 ± 11.3 49.7* ± 4.0 N/A 0.74 ± 0.14 0.72** ± 0.09 0.7 ± 0.12 2.16** ± 0.23 –0.24 ± 1.7
HRT group 44  155 ± 5.7 65.2 ± 12.6 53.2 ± 7.5 46.4 ± 5.7 0.76 ± 0.11 0.73** ± 0.12 0.71 ± 0.13 2.20** ± 0.26 –0.65 ± 1.33
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to untreated menopausal women. The conservation of interver-
tebral disc height depends on the maintenance of the various
components of the disc. In health the two anatomical elements
of the disc, the nucleus pulposus and annulus fibrosus, contain
a proportionate distribution of collagen types, elastin, hydrophilic
glycosaminoglycans and water.
Prior to the third decade the nucleus pulposus contains colla-
gen types IV, II and IX, the major glycosaminoglycan being
aggrecan, and more importantly, ∼80% of its weight is water
(Eyre and Muir, 1977). The aggrecan chains contain a greater
chondroitin VI sulphate:chondroitin IV sulphate ratio. Moreo-
ver prior to the third decade of life, the chondroitin sulphate
VI:keratin sulphate ratio is elevated, maintaining more power-
ful hydrophilic activity (Johnstone and Bayliss, 1995). The
annulus fibrosus has a concentration of type I collagen in its
outer layers and type II in the inner lamellae (Nerlich et al.,
1997; Boos et al., 2002).
The above anatomical distribution in healthy intervertebral
discs provides these structures with efficient viscoelastic prop-
erties. These viscoelastic properties allow the disc to sustain
heavy loads and to distribute the pressure evenly on to the
other components of the spinal column. The cartilaginous end-
plate contains a number of perforations between the medullary
cavity of the vertebra and the intervertebral disc. On compression,
Figure 1. Total intervertebral disc height in different groups of women. D1–D3: total height.
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Figure 2. Lumbar disc 2 height in different groups of women.
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a fluid flux occurs whereby fluid in the intervertebral disc is
squeezed out to enter the medullary cavity. On relieving the
compression, the hydrophilic nature of the intervertebral disc
reabsorbs the fluid previously relinquished, and in doing so the
disc acts as a vital tissue pump. Simultaneously nutrition of the
disc and removal of waste products occurs (Sagi et al., 2003).
By the end of the third decade the blood supply to the
nucleus pulposus is obliterated (Brown and Tsaltas, 1976).
This starts a cascade of changes leading to alteration in the col-
lagen content, dehydration of the nucleus pulposus and
changes in the glycosaminoglycans (Urban et al., 1979). The
collagen types I, III and VI increasingly replace the other colla-
gens in both the annulus fibrosus and nucleus pulposus (Ner-
lich et al., 1997; Boos et al., 2002).
Disc fibrosis, deformity and loss of disc height occur with
increasing degeneration. The degenerating disc will be less
able to provide stability and will be less efficient at distributing
the applied loads evenly. The nucleus pulposus becomes a hard
sequestered ball in the middle of the intervertebal disc (Wil-
liams and Warwick, 1980).
The intervertebral disc has recently been shown to possess
the estrogen β receptor. Estrogen β receptor gene expression
was noted in intervertebral disc annulus fibrosis cells. Moreo-
ver culture of annulus fibrosus cells in the presence of 10–7 mol/l
17β-estradiol significantly increased cellular proliferation
(Gruber et al., 2002).
The bone matrix theory expounded by Albright et al. (1940)
indicated the importance of the connective tissue element in
the genesis of post-menopausal osteoporosis. Collagen marker
studies elegantly reveal the close connection between bone
formation and bone breakdown during the menopause and the
influence estrogen replacement therapy has on these biomark-
ers (Prestwood et al., 1994; Muscat Baron et al., 1997b). Estro-
gen has been shown to regulate the degradation of organic
bone matrix via matrix metalloproteinases and cystein protein-
ases (Parikka et al., 2001). Carboxyl terminal propeptide of
type I collagen (PICP) increases significantly after the applica-
tion of estradiol to menopausal women (Sands et al., 2000).
Skin collagen content has been shown to decrease after the
menopause only to be reinstituted with the application of HRT
(Brincat et al., 1983).
HRT has also been shown to cause increased skin thickness,
presumably due to its effect on the collagen content (Brincat
et al., 1985). Alterations in collagen content induced by HRT
given to post-menopausal women have also been demonstrated
in other organs such as the cardiovascular system (Muscat
Baron et al., 1997a, 1998) and the urinary tract (Versi et al.,
1988).
Animal and human studies have suggested an effect of the
menopause on glycosaminoglycan content. Work on rats has
suggested that glycosaminoglycan content decreases following
castration, only to be regained after treatment with estradiol
(Horsfall et al., 1994). Hyaluronic acid content was shown to
increase sharply with estrogen (Horsfall et al., 1994; Sunil
et al., 2000). A consequent linear increase in water content was
also noted (Grosman, 1973).
Estradiol has been shown to modulate the inhibiting effect
of tissue inhibitory proteinases and proteoglycans on matrix
metalloproteinases. These matrix metalloproteinases are respons-
ible for their activity concerning the extracellular matrix-specific
gene switching of Colia IV and Colia I genes (Sudhakaran
et al., 1999).
In humans, hormonally stimulated menstrual cycles are
associated with an increase in proteoglycan concentrations
(Carranco et al., 1992). Estradiol significantly increased the
synthesis of sulphated glycosaminoglycans in uterine connec-
tive tissue of pregnant women (Wiqvist and Linde, 1987).
Urine ratio of glycosaminoglycans to creatinine increases
markedly in women after the menopause (Larking et al., 1987).
Moreover women with post-menopausal osteoporosis had a
significant increase in glycosaminoglycan excretion correlat-
ing with calcium excretion (Todorova et al., 1992).
The above effects of estrogen on basic components of the
intervertebral disc may explain the findings in this study.
Estrogen-replete women appear to maintain a healthy status of
the disc collagen and glycosaminoglycans. As a corollary to
the increase in hydrophilic glycosaminoglycans, the water con-
tent increases. This may explain the significantly greater height
of intervertebral discs in the pre-menopausal women and
hormone-treated women compared to the untreated post-
menopausal women.
The loss in disc height, especially in untreated menopausal
women as shown in this study, has a number of important
implications for risk of vertebral compression fracture. The
loss in height may lead to decreased compressibility resulting
in a diminished distance covered by the fluid pump when under
pressure.
The loss in circumferential disc height and increased promi-
nence of the hardened sequestered nucleus pulposus may
encourage perforation of the vertebral endplate and subsequent
vertebral body compression fracture. Moreover the reduction
of the viscoelastic properties of the disc further increase the
risk of deformity and eventual osteoporotic vertebral fracture.
A possible confounding variable in the hormone-treated
group is the heterogeneity of the hormonal regimens taken by
the women recruited. This illustrates the difficulty of perform-
ing hormonal treatment studies on post-menopausal women
and tailoring the regimen and route of administration to the
women’s wishes and needs. The large majority of the hormone-
treated women were on oral treatment with comparable
potency, suggesting a uniform hormonal influence of this
group. The smaller component of the treated group with
implants possibly equilibrated the lower potency transdermally
treated women.
The implant and transdermal groups and some women in the
untreated menopausal group had had a surgical menopause at
an early age, explaining the low mean age of menopause in
both groups of women. In the latter group the long-term estro-
gen deprivation may have not only led to a lower bone density
but may have contributed to a further lowering of intervertebral
disc heights. By contrast, the hormone-treated group man-
tained their disc height.
In conclusion, this study indicated that estrogen-replete
women appear to maintain higher and therefore healthier
intervertebral discs compared to untreated post-menopausal
women. The estrogenic environment may be of such influence
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because of the significant impact it has on the extracellular
matrix, in particular the glycosaminoglycans and the water
content of the intervertebral discs. Adequate disc height may
allow the intervertebral discs to retain their discoid anatomy
and viscoelastic function, possibly cushioning vertical forces
which may threaten osteoporotic spinal architecture leading to
vertebral crush fractures.
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